Zusammenfassung
Bei häufiger als 3mal pro Jahr, d. h. rezidivierend, auftretenden Harnwegsinfektionen (rHWI) (10–29% aller HWI-Patienten mit Zystitis und/oder Pyelonephritis), bei denen keine ursächlich anders zu therapierende Ursache vorliegt, sollte eine Rezidivprophylaxe in Erwägung gezogen werden.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Ahuja S, Kaack B, Roberts J (1998) Loss of fimbrial adhesion with the addition of Vaccinum macrocarpon to the growth medium of p-fimbriated Escherichia coli. J Urol 159: 559–562
Anderson RU (1987) Chemoprophylaxe bei Patienten mit Querschnittsläsionen. Akt Urol 18 (Suppl l): 28–30
Anonymus (1991) Antibiotics as biological response modifiers. Lancet 337: 400–401
Avorn J, Monane M, Gurwitz JH, Glynn RJ, Choodnovkiy I, Lipsitz LA (1994) Reduction of bacteriuria and pyuria after ingestion of cranberry juice. JAMA 271: 751–754
Bach D, Hesse A, Schaefer RM (1987) Harnansäuerung mit L-Methionin. Fortschr Med 105: 300–302
Bailey RR, Roberts AP, Gower PE, De Wardener HE (1971) Prevention of urinary-tract infection with low-dose Nitrofurantoin. Lancet 1112–1114
Bennett CJ, Young MN, Razi SS, Adkins R, Diaz F, McCrary A (1997) The effect of urethral introducer tip catheters on the incidence of urinary tract infection outcomes in spinal cord injured patients. J Urol 158: 519–521
Biering-Sorensen F, Hoiby N, Nordenbo A, Ravnborg M, Bruun B, Rahm V (1994) Ciprofloxacin as prophylaxis for urinary tract infection: prospective, randomized, cross-over, placebo controlled study in patients with spinal cord lesion. J Urol 151: 105–108
Blumberg EA, Abrutyn E (1997) Methods for the reduction of urinary tract infection. Curr Opin Urol 7: 47–51
Brandberg A, Mellström D, Samsioe G (1987) Low dose oral estriol treatment in elderly women with urogenital infections. Acta Obstet Gynaecol Scand 140 (Suppl): 33–38
Breithaupt H (1987) Grundlagen der Chemoprophylaxe unter besonderer Berücksichtigung von Trimethoprim und Nitrofurantoin aus klinisch-pharmakologischer Sicht. Akt Urol 18 (Suppl) 1: 2–5
Brühl P, Schumacher B, Knolle P (1984) PVP-Jod-Harnblasenspülung: Systemische Jodbelastung und Verträglichkeit. Urologe B 24: 218–222
Brumfitt W, Cooper J, Hamilton-Miller JMT (1981) Prevention of recurrent urinary infections in women: a comparative trial between Nitrofurantoin and Methenamine hippurate. J Urol 126: 71–74
Brumfitt W, Hamilton-Miller JMT, Gargan RA, Cooper J, Smith GW (1983) Long-term prophylaxis of urinary infections in women comparative trial of trimethoprim, methenamine hippurate and topical povidone-iodine. J Urol 130: 1110–1114
Buckley RM, McGuckin M, McGregor RR (1978) Urine bacterial counts after sexual intercourse. New Engl J Med 298: 321–324
Cass AS, Ireland GW (1985) Antibacterial perineal washing for prevention of recurrent urinary tract infections. Urology 25: 492–494
Chan RCY, Bruce AW, Reid G (1984) Adherence of cervical vaginal and distal urethral normal microbial flora to human uroepithelial cells and the inhibition of adherence of gram-negative uropathogens by competitive exclusion. J Urol 131: 596–601
Chessare JB (1992) Circumcision: is the risk of urinary tract infection really the pivotal issue? Clin Pediatr 31: 100–104
Chisholm GD (1982) Antimicrobial prophylaxis in urology and transplantation. World J Surg 6: 281–292
Coppa GV, Gabrielli O, Giorgi P, Catassi C, Montanari MP, Varaldo PE, Nichols BL (1990) Preliminary study of breastfeeding and bacterial adhesion to uroepithelial cells. Lancet 335: 569–571
Csef H (1997) Somatoforme Störungen in der Urologie. Urologe A 36: 87–99
Cunha BA (1988) Nitrofurantoin - current concepts. Urology 32: 67–71
Davis CP, Shirtliff ME, Scimeca JM, Hoskins SL, Warren MM (1995) In vivo reduction of bacterial populations in the urinary tract of catheterized sheep by iontophoresis. J Urol 154: 1948–1953
Deutsche Gesellschaft für Ernährung (1992) Empfehlungen für die Nährstoffzufuhr, 5. Aufl. Umschau, Frankfurt. 1. Korrektur, S 41–44
Dontas AS, Giamarellou H, Staszewska-Pistoni M, Zorbas P (1993) Urinary tract infections in the elderly. J Chemother 5 (Suppl) 1: 340–341
Duffy LM, Cleary J, Ahern S, Kuskowski MA, West M, Wheeler L, Mortimer JA (1995) Clean intermittent catheterization: safe, cost-effective bladder management for male residents of VA nursing homes. J Am Geriatr Soc 43: 865–870
Eckford SD, Keane DP, Lamond E, Jackson SR, Abrams P (1995) Hydration monitoring in the prevention of recurrent idiopathic urinary tract infections in pre-menopausal women. Br J Urol 76: 90–93
Elliott TSJ, Reid L, Gopal Rao G, Rigby RC, Woodhouse K (1989) Bladder irrigation or irritation? Br J Urol 64: 390–394
Fihn SD, Latham RH, Roberts P, Running K, Stamm WE (1985) Association between diaphragm use and urinary tract infection. J Am Med Assoc 254: 240–245
Fox BC, Sollinger HW, Beizer FO, Maki DG (1990) A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis. Am J Med 89: 255–274
Frey W, Suter F (1951) Handbuch der Inneren Medizin, Bd 8 Nieren und ableitende Harnwege. Springer, Berlin Göttingen Heidelberg, S 915
Fünfstück R, Straube E, Schildbach O, Tietz U (1997) Reinfektionsprophylaxe durch L-Methionin bei Patienten mit einer rezidivierenden Harnwegsinfektion. Med Klin 92: 574–581
Grischke EM, Rüttgers H (1987) Treatment of bacterial infections of the female urinary tract by immunization of the patients. Urol Int 42: 338–341
Grüneberg RN (1981) Prevention of recurrent urinary tract infection. Dial Transpl 10: 652–673
Hachen HJ (1990) Oral immunotherapy in paraplegic patients with chronic urinary tract infections: a double blind, placebo-controlled trial. J Urol 143: 759–762
Halverstadt DB, Leadbetter GW (1968) Internal urethrotomy and recurrent urinary tract infection in female children. I. Results in the management of infections. J Urol 100: 297–302
Hillig T (1974) Die Resistenzlage der wichtigsten Harnwegskeime gegenüber Nifurantin. Inauguraldissertation, Berlin
Hinman F (1966) Mechanisms for the entry of bacteria and the establishment of urinary infection in female children. J Urol 96: 546–550
Howe RA, Spencer RC (1996) Cotrimoxazole: rationale for re-examining its indications for use. Drug Safety 14: 213–218
Hubmann R, Brühl P (1966) Ergebnisse der Langzeitbehandlung der chronischen Cystopyelonephritis. Urologe 5: 15–18
Huland H (1987) Chemoprophylaxe bei Frauen mit rezidivierenden Harnwegsinfektionen. Akt Urol 18 (Suppl 1): 19–22
Iravani A (1991) Advances in the understanding and treatment of urinary tract infections in young women. Urology 37: 503–511
Jecht EW (1985) Hinweise für die persönliche Hygiene des jungen Mannes. Fortschr Med 103: 753–754
Kasanen A, Junnila SYT, Kaarsalo E, Hajba A, Sundquist H (1982) Secondary prevention of recurrent urinary tract infections. Scand J Infect Dis 14: 293–296
Kasanen A, Sundquist H, Elo J, Anttila M, Kangas L (1983) Secondary prevention of urinary tract infection. Ann Clin Res 15: 1–36
Kashiwagi A, Tanaka Y, Ogawa T, Asahina T, Ikebuchi M, Harada N, Shigeta Y (1991) Usefulness of low-dose ofloxacin administration for prevention of recurrent urinary tract infection in diabetic patients. Proceedings of the 3rd Int Symp on New Quinolones. Vieweg, Wiesbaden, p 99
Kindrachuk W, Thomas E, Stamey TA (1984) Cephalexin: efficacy of prophylaxis in women with recurrent urinary tract infections and biologic effects on rectal and vaginal flora. J Urol 131: 247A
Kotz CM, Peterson LR, Moody JA, Savaiano DA, Levitt MD (1990) In vitro antibacterial effect of yogurt on Escherichia coli. Dig Dis Sci 35: 630–637
Kraatz G, Scherber A (1988) Zur Nitrofurantoin-Prophylaxe rezidivierender Harnwegsinfektionen. Z Urol Nephrol 81: 641–645
Kramer A, Gutenbrunner C, Schultheis HM (1990) Untersuchungen über die Häufigkeit von Harnwegs-infektrezidiven vor und nach urologischen Kuren. Z Phys Med Baln Med Klin 19: 314–319
Kunin CM (1978) Sexual intercourse and urinary infection. New Engl J Med 298: 336–337
Lach PA, Elster AB, Rogham KJ (1980) Sexual behaviour and urinary tract infection. Nurse Practit 5: 27–32
Landes RR, Melnick I, Hoffman AA (1972) Betadine ointment topically applied to urethral meatus for prevention of recurring urinary tract infections in females. In: Polk HC, Ehrenkranz NJ (eds) Therapeutic advances and new clinical implications: medical and surgical antisepsis with Betadine microbicides. Purdue Frederick Company, Purdue, pp 149–151
Langermann S, Palaszynski S, Barnhart M, Auguste G, Pinkner JS, Burlein J, Barren P, Koenig S, Leath S, Jones CH, Hultgren SJ (1997) Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. Science 276: 607–611
Laufer B (1993) Infektanfälligkeit bei Frauen. Dtsch Med Wochenschr 118: 1782
Liedberg H, Lundberg T (1990) Silver alloy coated catheters reduce catheter-associated bacteriuria. Br J Urol 65: 379–381
Light RB, Ronald AR, Harding GKM, Dikkema J, Thompson L, Buckwold FJ (1981) Trimethoprim alone in the treatment and prophylaxis of urinary tract infection. Arch Intern Med 141: 1807–1810
Litschgi M (1987) Harnwegsinfektbehandlung mit SolcoUrovac. Geburtsh Frauenheilkd 47: 107–110
Loch E-G, Hellweg K (1985) Tampon oder Binde - (k)eine Alternative. Sexualmedizin 14: 498–503
Lumsden L, Hyner GC (1985) Effects of an educational intervention on the rate of recurrent urinary tract infections in selected female outpatients. Women Health 10: 79–86
Mack DJ, Smart L, Girdwood A, Scott PJW, Fulton JD, Erwin L (1993) Infection prophylaxis with lactulose. Age ageing 22 (Suppl 2): P8
Magasi P, Panovics J, Illes A, Nagy M (1994) Uro-Vaxom and the management of recurrent urinary tract infection in adults: a randomized multicenter double-blind trial. Eur Urol 26: 137–140
Marshall S (1965) The effect of bubble bath on the urinary tract. J Urol 93: 112
McCutcheon J, Fulton JD (1989) Lowered prevalence of infection with lactulose therapy in patients in long-term hospital care. J Hosp Infect 13: 81–86
Meroni PL, Palmieri R, Barcellini W, de Bartolo G, Zanussi C (1983) Effect of long-term treatment with Bacillus subtilis on the frequency of urinary tract infections in older patients. Chemioterapia 2: 142–144
Moorman CN, Fowler JE (1992) Impact of site release vaginal pH-buffer cream on introital colonization by gram-negative bacilli. J Urol 147: 1576–1578
Muscettola M, Grasso G, Blach-Olszewska Z, Migliaccio P, Borghesi-Nicoletti C, Giarratana M, Gallo VC (1992) Effects of Bacillus subtilis spores on interferon production. Abstracts band 8th Intern. Congr. Immunology, Budapest 23.-28.8. 1992. Springer, Budapest Berlin Heidelberg, p 189
Naber KG (1993) Antibiotikatherapie der unkomplizierten Zystitis der Frau. Urologe B 33: 318–322
Neu HC (1992) Urinary tract infections. Am J Med 92 (Suppl 4A): 63S–70S
Nicolle LE, Harding GKM, Preiksaitis J, Ronald AR (1982) The association of urinary tract infections with sexual intercourse. J Infect Dis 146: 579–583
Nicolle LE (1992) Prophylaxis: recurrent urinary tract infection in women. Infection 20 (Suppl 3): S203–S205
Olbing H (1987) Harnwegsinfektionen bei Kindern und Jugendlichen. Enke, Stuttgart, S 67
Orlander JD, Jick SS, Dean AD, Jick H (1992) Urinary tract infections and estrogen use in older women. J Am Geriatr Soc 40: 817–820
Pearman JW, Bailey M, Harper WES (1988) Comparison of the efficacy of “Trisdine” and kanamycin-colistin bladder instillations in reducing bacteriuria during intermittent catheterisation of patients with acute spinal cord trauma. Br J Urol 62: 140–144
Pearman JW, Bailey M, Riley LP (1991) Bladder instillations of Trisdine compared with catheter introducer for reduction of bacteriuria during intermittent catheterisation of patients with acute spinal cord trauma. Br J Urol 67: 483–490
Pfau A (1987) Therapie der unteren Harnwegsinfektionen beim Mann unter besonderer Berücksichtigung der chronischen bakteriellen Prostatitis. Akt Urol 18 (Suppl 1): 31–33
Pfau A, Sacks TG (1994) Effective postcoital quinolone prophylaxis of recurrent urinary tract infections in women. J Urol 152: 136–138
Raz R, Stamm WE (1993) A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. New Engl Med J 329: 753–736
Reichelt HW (1985) Ansäuerung des Harnes mit L-Methionin - eine effiziente Metaphylaxe bei rezidie-render Phosphatsteinbildung. Österr Z Allgemeinmed 39: 1636–1645
Riedasch G, Möhring K (1986) Immunisierungstherapie rezidivierender Harnwegsinfekte der Frau. Therapiewoche 10: 896–900
Riley DK, Classen DC, Stevens LE, Burke JP (1995) A large randomized clinical trial of a silver-impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. Am J Med 98: 349–356
Rüttgers H, Grischke EM (1987) Urinary tract infections in women. Urol Int 42: 342–347
Sachse D (1984) Therapie chronisch-rezidivierender Harnwegsinfekte mit Nitroxolin. Therapiewoche 34: 228–230
Schaeffer AJ, Story KO, Johnson SM (1988) Effect of silver oxide/trichloroisocyanuric acid antimicrobial urinary drainage system on catheter-associated bacteriuria. J Urol 139: 69–73
Schilcher H (1992)Phytotherapie in der Urologie. Hippokrates, Stuttgart
Schneider HJ (1990) Immunstimulation, neuer Therapieansatz bei rezidivierenden Harnwegsinfekten. Allgemeinarzt 12: 626–633
Schneider S, Stein G, Schmidt S (1983) Keimspektrum und Resistenzverhalten von Bakterien bei Harnwegsinfektionen junger Frauen. Dtsch Gesundheitswesen 38: 1495–1497
Simon C, Stille W (1993) Antibiotika-Therapie in Klinik und Praxis. Schattauer, Stuttgart New York, 8. Aufl, S 227–231
Stamm WE, Counts GW, Wagner KF, Martin D, Gregory D, McKevitt M, Turck M, Holmes KK (1980) Antimicrobial prophylaxis of recurrent urinary tract infections. Ann Intern Med 92: 770–775
Stöhrer M (1983) Harnwegsinfektionen bei neurogener Blasenentleerungsstörung. In: Stille W, Schilling A (Hrsg) Infektionen des Harntraktes. Zuckschwerdt, München Bern Wien, S 112–125
Svensson R, Larsson P, Lincoln K (1982) Low dose Trimethoprim prophylaxis in long term control of chronic recurrent urinary tract infection. Scand J Infect Dis 14: 139–142
Tammen H and the German Urinary Tract Infection Group (1990) Immunbiotherapy with Uro Vaxom in recurrent urinary tract infection. Br J Urol 65: 6–9
Torna H, Tanabe K, Sagara R (1989) Long-term prophylaxis with low nightly dose ofloxacin for complicated recurrent urinary tract infection (UTI). 16th Int Congr Chemother, Jerusalem, Abstracts, p 187
Turck M, Peterdorf RG (1962) The epidemiology of non-enteric Escherichia coli infections: prevalence of serologic groups. J Clin Invest 41: 1760–1765
Uehling DT, Hopkins WJ, Balish E, Xing Y, Heisey DM (1997) Vaginal mucosal immunization for recurrent urinary tract infection: phase II clinical trial. J Urol 157: 2049–2052
Vahlensieck W (1974) Rezidivierende Zystitis. Therapiewoche 24: 3631–3637
Vahlensieck W jr (1991) Immunologische Aspekte rezidivierender Harnwegsinfektionen. Bericht vom Symposium in Lübeck/Travemünde, 13.4.1991. Akt Urol 22 (Suppl): 1–4
Vahlensieck W jr (1993) Diagnostisches Stufenprogramm bei Harnwegsinfektionen. Niere Blase Prostata 18: 121
Vahlensieck W jr, Schander K (1986) Vergleich der Häufigkeit und Ursachen von Miktionsstörungen bei chirurgischen und streßinkontinenten Patientinnen. Z Urol Nephrol 79: 189–195
Vahlensieck W jr, Hofstetter A (1991) Harnwegsinfektion und Streßinkontinenz bei der Frau. Münch Med Wochenschr 133: 532–534
Vahlensieck W jr, Westenfelder M (1992) Nitrofurantoin versus Trimethoprim for low-dose long term prophylaxis in patients with recurrent urinary tract infections - a prospective randomized study. Int Urol Nephrol 24: 3–10
Vahlensieck W jr, Hofstetter A (1993) Aktuelle Chemotherapie bei Harnwegsinfektionen. Urologe A 32: 30–34
Vahlensieck Wjr, Eulitz (1998) Prophylaxis of recurrent urinary tract infections with immune response modifiers. (In Vorbereitung) Vahlensieck W, Hesse A, Nolde A (1993) Urolithiasis: Der Stein ist raus, was nun? Urologe A 32: 347–357
Vahlensieck W jr, Bichler KH, Münch L, Naber KG, Hubmann R, Hofstetter A, Weidner W (1994) Allgemeine Prophylaxemaßnahmen bei geschlechtsaktiven Patientinnen mit rezidivierenden Zystitiden. Urologe B 34: 219–221
Vogt P, Schorn T, Repp H, Frei U, Pichlmayr R (1989) Experience with ofloxacin for short and long-term treatment of urinary tract infections in renal transplant recipients. J Chemother 1 (Suppl 4): 856–857
Voss F (1991) Der Einfluß des Miktionsverhaltens und der Pubertät auf Pathogenese und Verlauf der Harntraktinfektion bei Mädchen. In: Stein G, Fünfstück R (Hrsg) Harnwegsinfektion. Pmi, Frankfurt, S 158–161
Vosti KL (1975) Recurrent urinary tract infections: prevention by prophylactic antibiotics after sexual intercourse. J Am Med Assoc 231: 934–940
Wagenknecht LV (1977) Lokale Instillationstherapie bei Zystitiden. In: Die medikamentöse Beeinflussung oxidativer Zellstoffwechselprozesse und ihre klinische Bedeutung (kein Hrsg). Schnetztor, Konstanz, S 50 ff
Walther H (1977) Indikationsstellung und klinisch-pharmakologische Grundsätze bei der antibakteriellen Chemotherapie. Z Ärztl Fortb 71: 342–345
Wan J, Kaplinsky R, Greenfield S (1995) Toilet habits of children evaluated for urinary tract infection. J Urol 154: 797–799
Weidner W, Weißbach L, Eickenberg H-U, Carl P, Meyer W (1985) Trimethoprim und Cotrimoxazol zur Prophylaxe der rezidivierenden unkomplizierten Harnwegsinfektion der Frau. Urologe B 25: 124–126
Westenfelder M, Ungemach G (1981) L-Methionin zur Ansäuerung des Urins. Therapiewoche 31: 5197–5200
Westenfelder M, Pelz K, Frankenschmidt A, Vahlensieck W jr (1987a) Klinische Prüfung der Effektivität und Verträglichkeit von Norfloxacin in der Therapie komplizierter Harnwegsinfektionen und in der Langzeitprophylaxe rezidivierender Harnwegsinfektionen. Infection 15: 20–24
Westenfelder M, Vahlensieck W jr, Reinartz U (1987b) Patientencompliance und Effektivität der anti-mikrobiellen Langzeitprophylaxe mit Niedrigdosen bei Patienten mit rezidivierenden Harnwegsinfektionen (rHWI). Akt Urol 18 (Suppl 1): 6–9
Whitmore KE (1994) Editorial: bladder infection. J Urol 152: 868
Wong ES, McKevitt M, Running K, Counts GW, Turck M, Stamm WE (1985) Management of recurrent urinary tract infections with patient-administered single dose therapy. Ann Intern Med 102: 302–307
Wong HY, Riedl CR, Griffith DP (1995) The effect of iontophoresis on bacterial growth in urine. J Urol 154: 1944–1947
Zorbas P, Giamarellou H, Staszewska-Pistoni M, Petrikkos G, Grammatikou M, Dontas AS (1994) Three months treatment of bacteriuria in elderly subjects under two oral ofloxacin (of) regimens compared to untreated subjects and followed for six months. 5th Int Symp on New Quinolones, Program and Abstracts, p 233, abs 180
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Vahlensieck, W. (1999). Prophylaxemaßnahmen bei rezidivierenden Harnwegsinfektionen. In: Hofstetter, A. (eds) Urogenitale Infektionen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59883-8_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-59883-8_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64165-7
Online ISBN: 978-3-642-59883-8
eBook Packages: Springer Book Archive